ERBB2 and breast carcinoma: Of note, the cytotoxicity of NK-92/5.28.z cells against aRMS cells was similar to that of NK-92/5.28.z cells against MDA-MB-453 breast cancer cells, which highly overexpress ERBB2 [30].